Current Advances of Nanomaterial-Based Oral Drug Delivery for Colorectal Cancer Treatment

26Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

Colorectal cancer (CRC) is a common malignant tumor, and traditional treatments include surgical resection and radiotherapy. However, local recurrence, distal metastasis, and intestinal obstruction are significant problems. Oral nano-formulation is a promising treatment strategy for CRC. This study introduces physiological and environmental factors, the main challenges of CRC treatment, and the need for a novel oral colon-targeted drug delivery system (OCDDS). This study reviews the research progress of controlled-release, responsive, magnetic, targeted, and other oral nano-formulations in the direction of CRC treatment, in addition to the advantages of oral colon-targeted nano-formulations and concerns about the oral delivery of related therapeutic agents to inspire related research.

Cite

CITATION STYLE

APA

Wang, N., Chen, L., Huang, W., Gao, Z., & Jin, M. (2024, April 1). Current Advances of Nanomaterial-Based Oral Drug Delivery for Colorectal Cancer Treatment. Nanomaterials. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/nano14070557

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free